Literature DB >> 1838141

Dynamic SPECT in two healthy volunteers to determine the optimal time for in vivo D2 dopamine receptor imaging with 123I-IBZM using the rotating gamma camera.

N P Verhoeff1, T Brücke, I Podreka, M Bobeldijk, P Angelberger, E A Van Royen.   

Abstract

Dynamic SPECT was performed in two healthy male volunteers with a single slice brain dedicated camera (Strichman Medical Equipment 810, first study) and a rotating gamma camera (Siemens Dual Rota ZLC37, second study) to obtain information about the optimal imaging time for the dopamine D2 receptor specific ligand 123I-(S)-(-)-2-hydroxy-3-iodo-6-methoxy-N[(1-ethyl-2-pyrrolidinyl) methyl]-benzamide (123I-IBZM). Count rates in the basal ganglia and in several cerebral cortical regions were used to define specific and aspecific binding, respectively. On the basis of the first study, 90-150 min seemed the optimal time for rotating gamma camera 123I-IBZM-SPECT. On the basis of the second study the optimal period was considered to be 60-120 min. It is recommended to apply the same imaging time after injection in a protocol to all patients and volunteers as otherwise a comparison may not be reliable.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838141     DOI: 10.1097/00006231-199108000-00004

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  5 in total

1.  A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.

Authors:  P Tibbo; P H Silverstone; A J McEwan; J Scott; A Joshua; K Golberg
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

2.  IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies.

Authors:  Ralph Buchert; Georg Berding; Florian Wilke; Brigitte Martin; Daniel von Borczyskowski; Janos Mester; Winfried Brenner; Malte Clausen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-14       Impact factor: 9.236

3.  Dopamine D2 receptor SPECT imaging: basic in vivo characteristics and clinical applications of 123I-IBZM in humans.

Authors:  H Toyama; M Ichise; J R Ballinger; L Fornazzari; J C Kirsh
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

4.  Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma.

Authors:  N P Verhoeff; F J Bemelman; W M Wiersinga; E A van Royen
Journal:  Eur J Nucl Med       Date:  1993-06

5.  Dosimetry of iodine-123 iodobenzamide in healthy volunteers.

Authors:  N P Verhoeff; E B Sokole; M Stabin; D Hengst; H F Kung; E A Van Royen; A G Janssen
Journal:  Eur J Nucl Med       Date:  1993-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.